5.43
-1.45%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About CNSIG Inner Mongolia Chemical Industry Co
Its shares trade on Shanghai under the ticker 600328.SS. It has been listed since 22 December 2000. In the fiscal year to 31 December 2025, it reported revenue of CN¥11.34bn and net income of CN¥73.9m. At that date it held total assets of CN¥26.88bn and shareholders' equity of CN¥12.00bn.
CNSIG Inner Mongolia Chemical Industry Co., Ltd. engages in the production and distribution of salt products, other chemical products, and pharmaceutical products. The company is headquartered in Alxa, Neimenggu. The company went IPO on 2000-12-22. The firm operates four segments: Salt Chemical segment, Salt segment, Pharmaceutical segment and others segment. The firm's main products include refined salt, industrial salt, sodium metal, sodium chlorate, soda ash, cistanche yishen granules, compound licorice tablets, vitamin algae, polyvinyl chloride resin, caustic soda, paste resin, calcium carbide and so on. The firm conducts its businesses within the domestic market and to overseas markets.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Materials
- Industry
- Chemicals
- Listed since
- 22 Dec 2000
- Employees
- 9,346
- Website
- chinasaltchemical.com ↗
Leadership
Pay as last reported
- Mr. Jie ZhouChairman of the Board, since 2021CN¥875,100
- Mr. Guangbin WangGeneral Manager, Director, since 2021CN¥409,300
- Mr. Sanji DuanDeputy General ManagerCN¥717,000
- Mr. Guoqing GuoDeputy General Manager
- Mr. Kaibao HuDeputy General ManagerCN¥719,100
- Mr. Duorong WangDeputy General Manager
- Mr. Ming XuDeputy General Manager
- Mr. Shengqiang ZhaoDeputy General Manager
- Mr. Yunquan ChenSecretary of the Board, Chief Accountant OfficerCN¥719,100
- Ms. Xuelian QiaoDirector
- Mr. Xianzhang QuDirectorCN¥636,200
- Mr. Jisuo WangDirector
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Produces a diverse range of chemical products including refined salt and sodium chlorate.
- Operates four business segments covering salt, pharmaceuticals, and other chemical products.
- Has a significant workforce of 9,346 employees.
Weaknesses
- Relies on domestic and overseas markets without specifying market share or growth potential.
- No information provided on financial performance or profitability metrics.
- Operates in a competitive materials sector with potential for market saturation.
Opportunities
- Expands into pharmaceutical products such as cistanche yishen granules and compound licorice tablets.
- Potential for growth in the domestic market and overseas markets.
- Diversified product portfolio including sodium metal and polyvinyl chloride resin.
Threats
- Competition in the materials sector may impact market share.
- Dependence on domestic and overseas markets could be affected by economic downturns.
- No information on environmental regulations or sustainability practices.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.